Literature DB >> 3947407

Homologous type II collagen induces chronic and progressive arthritis in mice.

R Holmdahl, L Jansson, E Larsson, K Rubin, L Klareskog.   

Abstract

Native mouse type II collagen was used for immunization of DBA/1 mice. Arthritis developed exclusively in male animals and was characterized by a variable and delayed onset, a slow and progressive development, and frequent exacerbations of disease in several joints including those that were previously affected. Titers of anti-type II collagen autoantibodies were found not to correlate well with arthritis development. It appears that experimental arthritis induced with homologous type II collagen resembles rheumatoid arthritis in humans, both in certain clinical features and in the lack of correspondence between anti-type II collagen autoantibody titers and disease symptoms.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3947407     DOI: 10.1002/art.1780290114

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  60 in total

Review 1.  Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.

Authors:  R O Williams; M Feldmann; R N Maini
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 2.  Analysing the effect of novel therapies on cytokine expression in experimental arthritis.

Authors:  Richard O Williams; Julia J Inglis; Egle Simelyte; Gabriel Criado; Percy F Sumariwalla
Journal:  Int J Exp Pathol       Date:  2005-10       Impact factor: 1.925

Review 3.  Rodent models of arthritis: relevance for human disease.

Authors:  R O Williams
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

Review 4.  Combination therapy in mice: what can we learn that may be useful for understanding rheumatoid arthritis?

Authors:  R O Williams
Journal:  Springer Semin Immunopathol       Date:  1998

Review 5.  Gene therapy for rheumatoid arthritis.

Authors:  P D Robbins; C H Evans; Y Chernajovsky
Journal:  Springer Semin Immunopathol       Date:  1998

6.  B cell-deficient mice do not develop type II collagen-induced arthritis (CIA).

Authors:  L Svensson; J Jirholt; R Holmdahl; L Jansson
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

Review 7.  Gene therapy for rheumatoid arthritis. Theoretical considerations.

Authors:  Y Chernajovsky; A Annenkov; C Herman; K Triantaphyllopoulos; D Gould; H Dreja; S P Moyes; J L Croxford; R A Mageed; O L Podhajcer; D Baker
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

8.  Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis.

Authors:  B Sheil; J McCarthy; L O'Mahony; M W Bennett; P Ryan; J J Fitzgibbon; B Kiely; J K Collins; F Shanahan
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

9.  Enforced expression of roquin protein in T cells exacerbates the incidence and severity of experimental arthritis.

Authors:  Young Rae Ji; Hei Jung Kim; Dong Hoon Yu; Ki Beom Bae; Seo Jin Park; Jun Koo Yi; Nari Kim; Si Jun Park; Keon Bong Oh; Sung Soo Hwang; Sanggyu Lee; Sung-Hyun Kim; Myoung Ok Kim; Jeong Woong Lee; Zae Young Ryoo
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

10.  Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene.

Authors:  Malin Hultqvist; Peter Olofsson; Jens Holmberg; B Thomas Bäckström; Jesper Tordsson; Rikard Holmdahl
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.